rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2003-8-7
|
pubmed:abstractText |
Treatment of ankylosing spondylitis (AS) with infliximab, an anti-tumor necrosis factor alpha monoclonal antibody, was shown to be efficacious in patients with active disease during a 3-month treatment period. The purpose of this study was to evaluate the efficacy and safety of infliximab treatment of AS for a 1-year period.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0004-3591
|
pubmed:author |
pubmed-author:AlteaEE,
pubmed-author:BrandtJJ,
pubmed-author:BraunJJ,
pubmed-author:BurmesterGG,
pubmed-author:GoldenSS,
pubmed-author:Gromnica-IhleEE,
pubmed-author:KellnerHH,
pubmed-author:ListingJJ,
pubmed-author:ReddigJJ,
pubmed-author:SörensenHH,
pubmed-author:SchneiderMM,
pubmed-author:SieperJJ,
pubmed-author:ZeidlerHH,
pubmed-author:ZiniGG
|
pubmed:issnType |
Print
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2224-33
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12905476-Acute-Phase Proteins,
pubmed-meshheading:12905476-Adult,
pubmed-meshheading:12905476-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:12905476-Antibodies, Antinuclear,
pubmed-meshheading:12905476-Antibodies, Monoclonal,
pubmed-meshheading:12905476-Antirheumatic Agents,
pubmed-meshheading:12905476-Female,
pubmed-meshheading:12905476-Humans,
pubmed-meshheading:12905476-Male,
pubmed-meshheading:12905476-Middle Aged,
pubmed-meshheading:12905476-Placebos,
pubmed-meshheading:12905476-Spondylitis, Ankylosing,
pubmed-meshheading:12905476-Treatment Outcome
|
pubmed:year |
2003
|
pubmed:articleTitle |
Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial.
|
pubmed:affiliation |
Benjamin Franklin Hospital, Free University, Berlin, Germany. J.Braun@rheumazentrum-ruhrgebiet.de
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|